Skip to main content
OpenTrials

Clinical trial condition

Skin Diseases

Explore clinical trials studying Skin Diseases. Study availability and eligibility vary by location and protocol.

416 public trials 47 recruiting studies
Refine in advanced search Browse all conditions

Skin Diseases trial results

Completed

Secukinumab Dosage Optimisation in Partial Responders With Moderate to Severe Plaque-type Psoriasis

NCT02474069

Conditions
Moderate to Severe Plaque-type Psoriasis, Pathological Conditions, Anatomical, Pathological Conditions, Signs and Symptoms, +6 more
Locations
  • Novartis Investigative Site Bad Bentheim, Germany
  • Novartis Investigative Site Berlin, Germany
  • Novartis Investigative Site Berlin, Germany
  • Novartis Investigative Site Berlin, Germany
View all 89 locations
View Trial Details
Completed

Visible Light Study

NCT02663921

Conditions
Pathologic Processes, Pathological Conditions, Signs and Symptoms, Pigment Disorders, +4 more
Locations
  • New York University School of Medicine New York, United States
View Trial Details
Completed

A Study of LY3041658 in Participants With Skin Diseases

NCT02896868

Conditions
Psoriasis, Skin Diseases, Skin Diseases, Papulosquamous, +1 more
Locations
  • Parexel Early Phase Unit at Glendale Glendale, California, United States
  • Dawes Fretzin Clinical Research Indianapolis, Indiana, United States
  • PAREXEL-Phase 1 Baltimore Harbor Hospital Center Baltimore, Maryland, United States
  • Duke University Medical Center Durham, North Carolina, United States
View Trial Details
Completed

Study to Evaluate Psoriasis Severity and Its Psychosocial Impact Using the Simplified Psoriasis Index (SPI), as Well as Long-term Safety, Tolerability and Efficacy of Secukinumab Administered Subcutaneously in Patients With Moderate to Severe Psoriasis

NCT02595970

Conditions
Disease Attributes, Pathologic Processes, Pathological Conditions, Anatomical, +10 more
Locations
  • Novartis Investigative Site Le Mans, Cedex 09, France
  • Novartis Investigative Site Limoges, Haute Vienne, France
  • Novartis Investigative Site Toulon, Val De Marne, France
  • Novartis Investigative Site Amiens, France
View all 17 locations
View Trial Details
Completed

Study to Assess the Efficacy, Safety and Tolerability of Secukinumab in Japanese Subjects With Generalized Pustular Psoriasis (GPP)

NCT01952015

Conditions
Psoriasis, Skin Diseases, Skin Diseases, Papulosquamous, +1 more
Locations
  • Novartis Investigative Site Fukuoka, Japan
  • Novartis Investigative Site Kitakyushu, Fukuoka, Japan
  • Novartis Investigative Site Asahikawa, Hokkaido, Japan
  • Novartis Investigative Site Sapporo, Hokkaido, Japan
View Trial Details
Completed

A Randomized, Open-label, Comparative Study to Evaluate an Intermittent Dosing Regimen of Fluticasone Propionate 0.05% Cream (Twice Per Week) in Reducing the Risk of Relapse When Added to Regular Daily Moisturization Using PHYSIOGEL Lotion in Paediatric Subjects With Stabilized Atopic Dermatitis

NCT01915914

Conditions
Skin Diseases, Skin and Connective Tissue Diseases
Locations
  • GSK Investigational Site Shenzhen, Guangdong, China
  • GSK Investigational Site Changsha, Hunan, China
  • GSK Investigational Site Beijing, China
  • GSK Investigational Site Shanghai, China
View Trial Details
Completed

Judging the Efficacy of Secukinumab in Patients With Psoriasis Using AutoiNjector: a Clinical Trial Evaluating Treatment Results (JUNCTURE)

NCT01636687

Conditions
Disease Attributes, Pathologic Processes, Pathological Conditions, Anatomical, +11 more
Locations
  • Novartis Investigative Site Phoenix, Arizona, United States
  • Novartis Investigative Site Los Angeles, California, United States
  • Novartis Investigative Site Oceanside, California, United States
  • Novartis Investigative Site Overland Park, Kansas, United States
View all 39 locations
View Trial Details

Related conditions